New Enterprise Associates 14, L.P.'s Net Worth
$177 Million
Who is New Enterprise Associates 14, L.P.?
New Enterprise Associates 14, L.P. has an estimated net worth of $177 Million. This is based on reported shares across multiple companies, which include MULESOFT, INC, Oyster Point Pharma, Inc., APPIAN CORP, Mersana Therapeutics, Inc., Adaptimmune Therapeutics PLC, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Galera Therapeutics, Inc., Tracon Pharmaceuticals, Inc., SYNLOGIC, INC., Cerecor Inc., IMARA Inc., Casper Sleep Inc., ZeroFox Holdings, Inc., Strongbridge Biopharma plc, and INTERLEUKIN GENETICS INC.
SEC CIK
New Enterprise Associates 14, L.P.'s CIK is 0001544328
Past Insider Trading and Trends
2018 was New Enterprise Associates 14, L.P.'s most active year for acquiring shares with 13 total transactions. New Enterprise Associates 14, L.P.'s most active month to acquire stocks was the month of February. 2022 was New Enterprise Associates 14, L.P.'s most active year for disposing of shares, totalling 19 transactions. New Enterprise Associates 14, L.P.'s most active month to dispose stocks was the month of December. 2017 saw New Enterprise Associates 14, L.P. paying a total of $24,009,000.00 for 58,948,211 shares, this is the most they've acquired in one year. In 2017 New Enterprise Associates 14, L.P. cashed out on 70,082,988 shares for a total of $66,073,750.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.1709
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.36M |
$12.00 |
—
| 4.36M |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oyster Point Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.93M |
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +1,737.54% | 5.6M |
$16.00 |
—
| 5.93M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mersana Therapeutics, Inc. (MRSN) Snapshot price: $3.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -25.13% | -2.00M |
—
|
—
| 5.96M |
Sep 14
| |||
Form 4
| -33.45% | -4.00M |
—
|
—
| 7.96M |
Apr 9
| |||
Form 4
| +0.58% | 69.38K |
$1.48 | $5.64 | 11.96M |
Aug 28
| |||
Form 4
| +46.07% | 3.75M |
$4.00 | $15,000,000.00 | 11.89M |
Mar 5
| |||
Form 4
|
∞
| 8.14M |
$15.00 |
—
| 8.14M |
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Casper Sleep Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.22M |
$6.90 | -$42,935,263.80 |
0
|
Jan 25
| |||
Form 4
| +25.14% | 1.25M |
$12.00 | $15,000,000.00 | 6.22M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMARA Inc. (ELVN) Snapshot price: $15.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -21.01% | -694.55K |
$1.08 | -$751,255.76 | 2.61M |
Apr 5 - Apr 6
| |||
Form 4
| -3.91% | -134.56K |
$1.50 | -$202,208.87 | 3.31M |
Jan 21 - Jan 25
| |||
Form 4
| -0.77% | -26.55K |
$1.83 | -$48,725.97 | 3.44M |
Jan 18 - Jan 20
| |||
Form 4
| -0.62% | -21.55K |
$1.94 | -$41,826.49 | 3.47M |
Jan 12 - Jan 14
| |||
Form 4
| -0.53% | -18.76K |
$2.07 | -$38,739.78 | 3.49M |
Jan 7 - Jan 11
| |||
Form 4
| -0.90% | -31.92K |
$2.26 | -$72,188.58 | 3.51M |
Jan 4 - Jan 6
| |||
Form 4
| -3.19% | -116.48K |
$2.29 | -$266,870.49 | 3.54M |
Dec 30 - Jan 3
| |||
Form 4
| -1.81% | -67.43K |
$2.37 | -$159,499.83 | 3.66M |
Dec 27 - Dec 29
| |||
Form 4
| -7.25% | -291.15K |
$2.36 | -$688,499.19 | 3.72M |
Dec 9 - Dec 23
| |||
Form 4
|
∞
| 4.01M |
$16.00 |
—
| 4.01M |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||